Nanobots, miniature robots 10 times smaller than a blood cell, are poised to revolutionise the healthcare industry. Nanotechnology, in combination with next-generation software platforms and supervised machine learning, provide a wide range of powerful diagnostic, monitoring and treatment tools. Chu Canh Chieu provides an insight into the future of nanobots in healthcare.
Designed to carry out a very specific task, nanobots can hunt for cells with identifiable characteristics; carry a payload of medicine for delivery to a specific place in the body and take a camera through a particular route to organs. With delivery options including an oral pill and injection, nanobots can be guided and accurately targeted while remaining minimally invasive and avoiding collateral damage, such as occurs with treatments like chemotherapy
The 2023 SNS Insider report indicates that The Nanorobotics Market reached USD 7.46 billion in 2022 and is projected to hit USD 17.56 billion by 2030. Transparency Market Research expects the nanorobotics in medicine market to reach USD 12.6 billion by the end of 2031, citing the increase in adoption of nanorobots in pharmacokinetics, diabetes monitoring, biomedical instrumentation and surgical procedures focusing on programming, controlling and designing nanoscale robots for various healthcare applications
Pinpoint accuracy
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
